This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Angus D, Linde-Zwirble W, Lidicker J, Clermont G, Carcillo J, Pinsky M (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303–1310
Annane D, Sebille V, Charpentier C et al. (2002) Effect of a treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288: 862–971
Bernard G, Vincent J, Laterre P et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709
Bone RC, Balk RA, Cerra FB et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101: 1644–1655
Briegel J, Forst H, Haller M et al. (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blinded, single-center study. Crit Care Med 27: 723–732
Dellinger RP (2003) Cardiovascular management of septic shock. Crit Care Med 31: 946–955
Hoyert D, Arias E, Smith B, Murphy S, Kochanek K (2001) National Vital Statistics Reports, Center for Disease Control and Prevention [serial online], 49(8), September, 21th 2001
Levy MM, Fink MP, Marshall JC et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250–1256
Lyseng-Williamson KA, Perry CM (2002) Drotrecogin alfa (activated). Drugs 62: 617–630; discussion 631–632
Moerer O, Schmid A, Hofmann M et al. (2002) Direct costs of severe sepsis in three German intensive care units based on retrospective electronic patient record analysis of resource use. Intensive Care Med 28: 1440–1446
Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273: 117–123
Rivers E, Nguyen B, Havstad S et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368–1377
Sprung CL, Bernard G, Dellinger RP (eds) (2001) Guidelines for the management of severe sepsis and septic shock. Intensive Care Med 27(Suppl 1)
Van den Berghe G, Wouters P, Weekers F et al. (2001) Intensive insulin therapy in the critically ill patients. N Engl J Med 345: 1359–1367
Vincent JL, Abraham E, Annane D, Bernard G, Rivers E, Van den Berghe G (2002) Reducing mortality in sepsis: new directions. Crit Care 6(Suppl 3): S1–18
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Schürholz, T., Ruschulte, H. (2005). Neue Aspekte der Sepsisbehandlung. In: Pharmakotherapie in der Urologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26450-7_16
Download citation
DOI: https://doi.org/10.1007/3-540-26450-7_16
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-23449-4
Online ISBN: 978-3-540-26450-7
eBook Packages: Medicine (German Language)